View from Washington

Jun 01, 2015
Applied Clinical Trials
Agency concerned about how proposals in "Cures" bill will be crafted and implemented.
Apr 01, 2015
Applied Clinical Trials
The productivity of the U.S. biomedical research enterprise is undergoing a broad re-examination.
Feb 01, 2015
Applied Clinical Trials
Agency proposes new standards in hopes of capitalizing on 2014 surge in new drug approvals.
Dec 01, 2014
Applied Clinical Trials
The promise is that customized delivery of injectible drugs and biologics will reduce toxicity, enhance individual response, facilitate the delivery of multiple drugs, minimize waste, and encourage patient adherence to prescribed treatment.
Nov 03, 2014
Applied Clinical Trials
There's a mounting campaign to encourage biopharmaceutical companies to develop new therapies to treat drug-resistant infections.
Oct 01, 2014
Applied Clinical Trials
The rush is on to develop new therapies and vaccines to combat the lethal outbreak.
Jul 01, 2014
Applied Clinical Trials
The mounting outrage over exorbitant prices for new medicines increases the importance of reducing the cost of biomedical product development.
Jun 01, 2014
Applied Clinical Trials
Congressional leaders have launched a major initiative to revise laws and regulatory policies to speed new cures to patients.
May 07, 2014
Applied Clinical Trials
A national publicity campaign recently succeeded in obtaining early access to an experimental treatment for a seriously ill child, touching off a broader discussion of compassionate use policies and their impact on drug development and approval.
Apr 01, 2014
Applied Clinical Trials
Despite guidances and rules advising sponsors to include all demographic groups in clinical trials, many subgroups remain underrepresented.
native1_300x100
lorem ipsum